
Sign up to save your podcasts
Or


Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.
Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.
By Axios4.3
689689 ratings
Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.
Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.

7,594 Listeners

37,435 Listeners

1,358 Listeners

1,052 Listeners

9,533 Listeners

1,515 Listeners

2,008 Listeners

87,290 Listeners

32,330 Listeners

2,135 Listeners

252 Listeners

12,504 Listeners

2,022 Listeners

4,366 Listeners

15,918 Listeners

10,760 Listeners

3,527 Listeners